Recently, billionaire Bill Gates had an article revealing a child
The European Drug Administration (EMA) has approved the introduction of the world's first malaria vaccine called Mosquirix in Africa.
A malaria vaccine in Phase II of a trial showed that after 4 years of injections, the protection effect against the disease was 0%, according to AFP on March 20.
Scientists at the Sanger Institute in Cambridge (UK) have discovered a way to penetrate red blood cells of malaria-causing parasites, promising to help develop effective vaccines.
The researchers said the first results of a vaccine against malaria showed that the drug halved the risk of disease in African children between 5 and 17 months of age.